SAN DIEGO, Sept. 3, 2020 /PRNewswire/ -- Arena
Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that that
members of its senior management team will participate in the
upcoming investor conferences:
- Wells Fargo Virtual Healthcare Conference – Presenting on
Wednesday, September 9, at
1:20 PM ET
- Citi 2020 BioPharma Virtual Conference – Hosting investor
meetings on Thursday, September
10
- H.C. Wainwright Virtual Global Investment Conference –
Presenting on Monday, September 14,
at 9:30 AM ET
- Cantor Virtual Global Healthcare Conference – Presenting on
Wednesday, September 16, at
2:00 PM ET
A live audio webcast of the available presentations will be
posted under the investor relations section of Arena's website at
www.arenapharm.com. A replay of the presentations will be available
for 30 days following each event.
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose –
deliver our important medicines to patients.
In a rapidly changing global market, we work with a sense of
urgency every day to understand the needs of all our stakeholders,
identify bold, sometimes disruptive, ideas to get our medicines to
patients, and relentlessly execute until it's done.
ARENA - Care More. Act Differently.
Forward-Looking Statements
Certain statements in this press release are forward-looking
statements that involve a number of risks and uncertainties. Such
forward-looking statements include statements about Arena's
participation in upcoming investor conferences and Arena's purpose,
work, understanding, ideas, and execution. For such statements,
Arena claims the protection of the Private Securities Litigation
Reform Act of 1995. Actual events or results may differ materially
from Arena's expectations. Factors that could cause actual results
to differ materially from the forward-looking statements include
those disclosed in Arena's filings with the Securities and Exchange
Commission. These forward-looking statements represent Arena's
judgment as of the time of this release. Arena disclaims any intent
or obligation to update these forward-looking statements, other
than as may be required under applicable law.
Corporate Contact:
Megan E.
Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations
mknight@arenapharm.com
858.210.3635
Arena Media Contact:
IR@arenapharm.com
858.453.7200
View original content to download
multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-participate-in-upcoming-investor-conferences-301124167.html
SOURCE Arena Pharmaceuticals, Inc.